Share on StockTwits

LipoScience (NASDAQ:LPDX) announced its earnings results on Wednesday. The company reported ($0.27) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.24) by $0.03, AmericanBankingNews.com reports.

Shares of LipoScience (NASDAQ:LPDX) opened at 2.99 on Wednesday. LipoScience has a 52 week low of $2.92 and a 52 week high of $5.59. The stock has a 50-day moving average of $3.24 and a 200-day moving average of $3.50. The company’s market cap is $45.6 million.

LipoScience, Inc is a vitro diagnostic company. The Company’s diagnostic test, the nuclear magnetic resonance (NASDAQ:LPDX) LipoProfile test, directly measures the number of low density lipoprotein (LDL), particles in a blood sample and provides physicians and their patients with actionable information to personalize management of risk for heart disease.

Receive News & Ratings for LipoScience Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LipoScience Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.